Weight-Loss Drugs Reduce Cancer Risk

Recent studies highlight the potential cancer-preventive benefits of GLP-1 drugs, commonly used for weight loss. Research indicates these medications may lower the risk of obesity-related cancers, particularly in women. This emerging evidence supports the dual health benefits of weight-loss treatments, offering both weight management and potential cancer protection.